Healthcare
By
Can Novo Nordisk’s New Semaglutide and Obesity Pipeline Data at EASD 2025 Redefine ‘Food Noise’ Control, Body Composition, and Cardiovascular Outcomes?
Key Highlights: Scientific Momentum at EASD 2025Novo Nordisk will present 35 abstracts across its diabetes and obesity portfolio…
Could GE HealthCare’s FDA-Cleared Revolution™ Vibe CT System Usher in a New Era of AI-Powered Cardiac Imaging?
Key Highlights Revolutionizing Cardiac Imaging with One-Beat ClarityGE HealthCare’s Revolution Vibe CT system has received U.S. FDA 510(k)…
Will GSK’s Fluviral Supply Strengthen Canada’s Seasonal Flu Preparedness?
Key Highlights Public Health ImpactAnnual flu vaccination remains the most effective tool to reduce flu-related risks. Vulnerable populations…
Could Roche’s New Vabysmo Data Redefine Long-Term Care in “wet” age-related macular degeneration (nAMD)?
Key Highlights Durability Demonstrated in AVONELLE-XRoche presented four-year data from AVONELLE-X at the Euretina 2025 Congress, showing that…
Will Tempus AI’s FDA Clearance Redefine the Future of Cardiac Imaging?
Key Highlights: Tempus AI Secures FDA Clearance for Tempus Pixel Tempus AI announced that its advanced imaging platform,…
Will GE HealthCare’s Acquisition of icometrix Redefine AI-Powered Neurology Imaging?
Chicago – GE HealthCare (Nasdaq: GEHC) announced it has entered into a definitive agreement to acquire icometrix, a…
